Please assess the completion status of the following clinical trial:

Trial Title: Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged ≥ 18 years~* Recent acute myocardial infarction, with or without ST- segment elevation, with a combination of ischemic symptoms occurring in the past 48 hours,before the MI related admission, and elevation of biomarkers of myocardial injury (troponin)~* Anemia Hb ≤ 10g / dL but \> 7 g/dL on Hb, measured at any time during the index hospital admission for MI.~* Written informed consent~* Coverage for medical insurance.~Exclusion Criteria:~* Shock (SBP \< 90 mmHg with clinical signs of low output or patients requiring inotropic agents)~* MI occurring post-percutaneous coronary intervention (PCI) or post-coronary artery bypass graft (CABG) (i.e. type IV or V Acute MI according to the 2012 Universal Definition of MI~* Life-threatening or massive ongoing bleeding (as judged by the investigator)~* Any blood transfusion in the previous 30-days~* any known malignant hematologic disease Note: Sickle cell disease, thalassemia and anemia due to chronic renal failure (even under EPO) are not an exclusion criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Restrictive transfusion strategy (Type: EXPERIMENTAL): Transfusions are withheld unless Hb is \<= 8 g/dL, with a target Hb of 8 to 10 g /dL
- Liberal transfusion strategy (Type: EXPERIMENTAL): Transfusions are allowed as soon as Hb \<= 10 g/dL with a target of 11 g /dL.

Based on this trial design, predict the completion outcome and termination type (if applicable).